QQQ   351.85 (+1.95%)
AAPL   162.55 (+1.73%)
MSFT   300.52 (+4.17%)
FB   301.75 (+0.53%)
GOOGL   2,632.85 (+3.71%)
AMZN   2,824.49 (+0.88%)
TSLA   950.75 (+3.52%)
NVDA   231.78 (+3.83%)
BABA   116.25 (-2.43%)
NIO   23.47 (-1.35%)
AMD   113.34 (+1.99%)
CGC   7.52 (+2.17%)
MU   83.25 (+3.13%)
GE   90.36 (-0.82%)
T   25.54 (-3.55%)
F   20.17 (+0.95%)
DIS   136.61 (+0.07%)
AMC   16.49 (+2.93%)
PFE   53.18 (+1.22%)
ACB   4.23 (+0.48%)
BA   196.33 (-3.81%)
QQQ   351.85 (+1.95%)
AAPL   162.55 (+1.73%)
MSFT   300.52 (+4.17%)
FB   301.75 (+0.53%)
GOOGL   2,632.85 (+3.71%)
AMZN   2,824.49 (+0.88%)
TSLA   950.75 (+3.52%)
NVDA   231.78 (+3.83%)
BABA   116.25 (-2.43%)
NIO   23.47 (-1.35%)
AMD   113.34 (+1.99%)
CGC   7.52 (+2.17%)
MU   83.25 (+3.13%)
GE   90.36 (-0.82%)
T   25.54 (-3.55%)
F   20.17 (+0.95%)
DIS   136.61 (+0.07%)
AMC   16.49 (+2.93%)
PFE   53.18 (+1.22%)
ACB   4.23 (+0.48%)
BA   196.33 (-3.81%)
QQQ   351.85 (+1.95%)
AAPL   162.55 (+1.73%)
MSFT   300.52 (+4.17%)
FB   301.75 (+0.53%)
GOOGL   2,632.85 (+3.71%)
AMZN   2,824.49 (+0.88%)
TSLA   950.75 (+3.52%)
NVDA   231.78 (+3.83%)
BABA   116.25 (-2.43%)
NIO   23.47 (-1.35%)
AMD   113.34 (+1.99%)
CGC   7.52 (+2.17%)
MU   83.25 (+3.13%)
GE   90.36 (-0.82%)
T   25.54 (-3.55%)
F   20.17 (+0.95%)
DIS   136.61 (+0.07%)
AMC   16.49 (+2.93%)
PFE   53.18 (+1.22%)
ACB   4.23 (+0.48%)
BA   196.33 (-3.81%)
QQQ   351.85 (+1.95%)
AAPL   162.55 (+1.73%)
MSFT   300.52 (+4.17%)
FB   301.75 (+0.53%)
GOOGL   2,632.85 (+3.71%)
AMZN   2,824.49 (+0.88%)
TSLA   950.75 (+3.52%)
NVDA   231.78 (+3.83%)
BABA   116.25 (-2.43%)
NIO   23.47 (-1.35%)
AMD   113.34 (+1.99%)
CGC   7.52 (+2.17%)
MU   83.25 (+3.13%)
GE   90.36 (-0.82%)
T   25.54 (-3.55%)
F   20.17 (+0.95%)
DIS   136.61 (+0.07%)
AMC   16.49 (+2.93%)
PFE   53.18 (+1.22%)
ACB   4.23 (+0.48%)
BA   196.33 (-3.81%)
OTCMKTS:CVSI

CV Sciences News Headlines

$0.15
+0.01 (+7.86%)
(As of 01/25/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.13
$0.15
50-Day Range
$0.10
$0.26
52-Week Range
$0.10
$1.12
Volume
350,650 shs
Average Volume
1.23 million shs
Market Capitalization
$17.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.86
Get CV Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVSI and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

CV Sciences Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CVSI
News Sentiment

0.00

0.33

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CVSI Articles
This Week

1

0

CVSI Articles
Average Week



CV Sciences (OTCMKTS:CVSI) News Headlines Today

SourceHeadline
MarketBeat logoCV Sciences (OTCMKTS:CVSI) Stock Price Up 7.8%
americanbankingnews.com - January 26 at 12:30 AM
finance.yahoo.com logoCV Sciences, Inc. Announces Launch of +PlusCBD™ Pain Relief Topicals
finance.yahoo.com - January 11 at 10:02 AM
benzinga.com logoCV Sciences Launches +PlusCBD Pain Relief Topicals With Products For Athletes, Arthritis Patients
benzinga.com - January 11 at 8:15 AM
msn.com logoNutrition Giant GNC To Distribute CBD Products In 770 Stores In US
msn.com - January 6 at 5:24 PM
msn.com logoIs Medical Marijuana Really A Slippery Slope? CVSI Distribution Agreement with GNC
msn.com - January 5 at 3:43 PM
seekingalpha.com logoCV Sciences signs distribution deal with GNC
seekingalpha.com - January 5 at 10:11 AM
finance.yahoo.com logoCV Sciences, Inc. Announces New Distribution Agreement with GNC
finance.yahoo.com - January 5 at 10:11 AM
finance.yahoo.com logoCV Sciences, Inc. Appoints Haskell & White LLP as Auditor
finance.yahoo.com - November 30 at 5:55 PM
finance.yahoo.com logoHere's Why CV Sciences, Inc. (CVSI) Looks Ripe for Bottom Fishing
finance.yahoo.com - November 23 at 2:45 PM
benzinga.com logoCV Sciences 3Q Financials Continue To Improve Cost Structure, Praises California CBD Legislation
benzinga.com - November 16 at 12:53 AM
nasdaq.com logoCV Sciences, Inc. (CVSI) Reports Break-Even Earnings for Q3
nasdaq.com - November 15 at 2:50 PM
finance.yahoo.com logoCV Sciences, Inc. Reports Third Quarter 2021 Financial Results
finance.yahoo.com - November 15 at 9:49 AM
finance.yahoo.com logoCV Sciences, Inc. Announces Convertible Note Financing
finance.yahoo.com - November 15 at 9:49 AM
benzinga.com logoEarnings Preview For CV Sciences
benzinga.com - November 12 at 12:15 PM
finance.yahoo.com logoCV Sciences, Inc. to Announce Third Quarter 2021 Results on November 15, 2021
finance.yahoo.com - November 8 at 9:17 AM
finance.yahoo.com logoWill CV Sciences, Inc. (CVSI) Report Negative Q3 Earnings? What You Should Know
finance.yahoo.com - October 28 at 7:35 PM
finance.yahoo.com logoCannabis Stocks to Radar for December
finance.yahoo.com - October 26 at 12:41 AM
benzinga.com logoEXCLUSIVE: CV Sciences Launches New Product Line Featuring Full Range Of Phytocannabinoids
benzinga.com - October 15 at 8:59 PM
finance.yahoo.com logoCV Sciences, Inc. Applauds the California Legislature for Passage of AB 45
finance.yahoo.com - October 7 at 5:47 PM
benzinga.com logoCantor Remains Neutral on Charlotte's Web, cbdMD and CV Science, Why These CBD Stocks May Benefit If Cannabis Reform Actually Happens
benzinga.com - August 13 at 10:16 PM
nasdaq.com logoCV Sciences, Inc. (CVSI) Reports Q2 Loss, Tops Revenue Estimates
nasdaq.com - August 13 at 2:07 AM
finance.yahoo.com logoCV Sciences, Inc. Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 12 at 9:07 PM
finance.yahoo.com logoCV Sciences, Inc. to Announce Second Quarter 2021 Results on August 12, 2021
finance.yahoo.com - August 5 at 12:01 PM
finance.yahoo.com logoCV Sciences, Inc. Receives NutraIngredients-USA 2021 Product of the Year: Immune Support Award
finance.yahoo.com - July 27 at 1:06 PM
msn.com logoCBD Can Reduce Nicotine Withdrawal Symptoms, Says New Study Done By CV Sciences
msn.com - July 22 at 4:23 PM
finance.yahoo.com logoCV Sciences, Inc. and University of California, San Diego Publish Study of Cannabidiol Efficacy in Treating Nicotine Dependence
finance.yahoo.com - July 20 at 9:58 AM
markets.businessinsider.com logoCantor Updates Ratings On Several Cannabis And CBD Stocks - MedMen, Jushi, cbdMD, CV Sciences
markets.businessinsider.com - June 18 at 12:54 PM
fool.com logoCV Sciences, Inc.(CVSI)
fool.com - June 11 at 12:13 AM
seekingalpha.com logoCV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - May 15 at 7:40 PM
finance.yahoo.com logoCV Sciences, Inc. Reports First Quarter 2021 Financial Results
finance.yahoo.com - May 13 at 7:37 PM
finance.yahoo.com logoCV Sciences, Inc. Announces Launch of PlusCBD™ Calm and Sleep Gummies
finance.yahoo.com - May 11 at 10:02 AM
finance.yahoo.com logoWill CV Sciences, Inc. (CVSI) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - May 7 at 7:21 PM
finance.yahoo.com logoCV Sciences, Inc. to Announce First Quarter 2021 Results on May 13, 2021
finance.yahoo.com - May 6 at 8:18 AM
finance.yahoo.com logoCV Sciences and Alkemist Labs Form Partnership to Support the National Institute of Standards and Technology’s Cannabis Quality Assurance Program
finance.yahoo.com - April 13 at 9:28 AM
benzinga.com logoA Preview Of CV Sciences's Earnings
benzinga.com - March 17 at 3:09 PM
markets.businessinsider.com logoHere's what Wall Street expects from CV Sciences's earnings
markets.businessinsider.com - March 16 at 1:15 PM
finance.yahoo.com logoCV Sciences, Inc. to Announce Fiscal Year and Fourth Quarter 2020 Results on March 18, 2021
finance.yahoo.com - March 10 at 8:02 AM
benzinga.com logoCV Sciences, Inc. to Announce Fiscal Year and Fourth Quarter 2020 Results on March 18, 2021
benzinga.com - March 10 at 7:06 AM
finance.yahoo.com logoWill CV Sciences, Inc. (CVSI) Report Negative Q4 Earnings? What You Should Know
finance.yahoo.com - March 8 at 3:03 PM
markets.businessinsider.com logoNews for CV Sciences Inc
markets.businessinsider.com - February 16 at 9:47 AM
markets.businessinsider.com logoCV Sciences Inc Neutral
markets.businessinsider.com - January 30 at 9:40 PM
benzinga.com logoCantor Fitzgerald Downgrades CV Sciences to Neutral, Lowers Price Target to $0.65
benzinga.com - January 29 at 12:44 PM
finance.yahoo.com logoCV Sciences, Inc. Announces Launch of ProCBD™ Product Line
finance.yahoo.com - January 5 at 1:26 PM
finance.yahoo.com logoCV Sciences, Inc. Announces Closing of Committed Equity Financing Transaction
finance.yahoo.com - December 8 at 8:45 AM
seekingalpha.com logoCV Sciences: CBD Is All The Rage Yet This Stock Will Get Ravaged
seekingalpha.com - December 3 at 7:42 AM
seekingalpha.com logoCV Sciences Inc's (CVSI) CEO Joe Dowling on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 6 at 8:37 AM
finance.yahoo.com logoCV Sciences, Inc. (CVSI) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 6 at 12:21 AM
marketwatch.com logoCV Sciences, Inc. Announces Launch of PlusCBD(TM) Pet Product Line
marketwatch.com - November 5 at 2:20 PM
finance.yahoo.com logoCV Sciences, Inc. Announces Launch of PlusCBD™ Pet Product Line
finance.yahoo.com - November 4 at 8:35 AM
finance.yahoo.com logoWill CV Sciences, Inc. (CVSI) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - October 29 at 6:03 PM
Get CV Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVSI and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/26/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.